AzTrials
AzTrials

Lateral EpicondylitisNCT05698108

Effects Of Instrument Assisted Soft Tissue Mobilization on Pain, Grip Strength and Functional Activity in Patients With Lateral Epicondylitis

A study testing Instrument Assisted Soft Tissue Mobilization (IASTM) and Conventional Physical Therapy in people with Lateral Epicondylitis and Tennis Elbow, run by University of Lahore at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to find the effects of Instrument Assisted Soft Tissue Mobilization (IASTM) using Ergon Tools on pain, grip strength and functional activity among patients diagnosed with Lateral epicondylitis. Read more about this study

Who is it for?
Ages 20 to 50 years
Conditions the study is for
Lateral Epicondylitis, Tennis Elbow
What is being tested?
Instrument Assisted Soft Tissue Mobilization (IASTM) and Conventional Physical Therapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 sitePakistan
Study dates
1 Mar 2022to 1 Nov 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Both Male and Female Patients
  • Patients between the age group 20-50 years
  • Sub-acute Patients having symptoms for > 6 weeks and < 3 months.
  • Patients who had pain rating from 5 to 9 in VAS will be included
  • Patients with Positive Cozens test, Mill's test

Who cannot join

  • Patients with any surgical or trauma history of the elbow
  • Rheumatoid Arthritis and Malignancies
  • Cervical Radiculopathy patients who have referred pain in the elbow
  • Loss of Passive ROM in extension
  • Active infections such as, Bursitis, Calcification of the soft tissues, Fragile skin, Hyper Mobility \& Joint Effusion
  • Hemophilic Patients
  • Osteoporosis
  • Patients with history of getting treatment with Steroid Injections will be excluded.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Sikander Medical Complex

    Chak One Hundred Seventy-five Nine Left, Pujab, 52250

Other trials in Pakistan

About this study

Official title: Effects Of Instrument Assisted Soft Tissue Mobilization Using Ergon Technique on Pain, Grip Strength and Functional Activity in Patients With Lateral Epicondylitis: A Randomized Controlled Trial

This study aimed to find the effects of Instrument Assisted Soft Tissue Mobilization (IASTM) using Ergon Tools on pain, grip strength and functional activity among patients diagnosed with Lateral epicondylitis.

The study concluded that IASTM is effective in improving pain, grip strength and functional activity in patients with lateral epicondylitis.

Read the detailed description

Background: Lateral Epicondylitis is a type of "repetitive strain injury" that causes pain on the lateral portion of the elbow, especially while gripping and applying resistance to the forearm's extensor muscles, both men and women are equally affected by it. Traditional Physical Therapy has failed to improve the disorders caused by LE, Instrument Assisted Soft Tissue Mobilization is a new approach for its treatment a lot of tools are being used and Ergon Tools are among one of them, very less data is available for its efficacy in lateral epicondylitis patients.

Objective: To compare the effects of Instrument Assisted Soft Tissue Mobilization using Ergon Technique on pain, grip strength and functional activity in patients with lateral epicondylitis.

Methodology: 72 individuals with lateral epicondylitis pre-diagnosed by an orthopedic surgeon, are assessed from Sikander Medical Complex, Gujranwala. After fulfilling the inclusion criteria, the participants are randomly divided into two groups, 36 participants receiving IASTM using Ergon Tools and 36 participants received conventional physical therapy. Both groups receive treatment 2 times a week for 4 weeks. Outcome measures are pain (VAS), grip strength (handheld dynamometer), and functional mobility (PRTEE) collected at the baseline, 1st week, and 4th week.

Being tested
Instrument Assisted Soft Tissue Mobilization (IASTM), Conventional Physical Therapy
Keywords
IASTM, Lateral Epicondylitis, tennis elbow, pain, grip strength, functional activity
Medical subject headings
Tennis Elbow, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Instrument Assisted Soft Tissue Mobilization (IASTM)Device

    Also called Ergon Tools

    Tools designed for soft tissue mobilization

  • Conventional Physical TherapyOther

    Also called Traditional Physical Therapy

    Moist Hot pack, Ultrasound, Deep Friction Massage, Stretching and Strengthening Exercises.

Study groups in NCT05698108
Study groupRoleWhat they receive
Conventional Physcial Therapy GroupActive comparatorAll participants received treatment 2 times a week for 4 weeks. Pre-treatment included a Moist hot pack for 10 minutes and traditional physical therapy included Cyriax Deep Friction Massage (DFM), Ultrasound therapy as well as strengthening and stretching exercises
Receives: Other: Conventional Physical Therapy
IASTM GroupExperimentalParticipants received Instrument Assisted Soft Tissue Mobilization Treatment 2 times a week for 4 weeks using Ergon IASTM tools.
Receives: Device: Instrument Assisted Soft Tissue Mobilization (IASTM)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain (mild to severe)

    Visual Analogue Scale The score is calculated by measuring the distance (mm) between the "no pain" anchor and the patient's mark on a 10-cm line with a ruler, yielding a range of 0-100. A higher score implies that the pain is more intense and a lower score suggests the intensity of pain to be milder. VAS ratings of 0 to 4 mm can be considered no pain; 5 to 44 mm, mild pain; 45 to 74 mm, moderate pain; and 75 to 100 mm, severe pain

    Measured: 4 weeks

  2. Grip Strength

    Digital Hand Held Dynamometer The best result from several trials for each hand is recorded, with at least 15 seconds recovery between each effort. The values listed below (in kg and lbs) give a guide to expected scores for adults. These values are the average of the best scores of each hand. See more Hand Grip Strength Norms. Other protocols will just use the score from the dominant hand, or compare the left and right hand results. See also examples of some actual athlete results.

    Measured: 4 weeks

  3. Functional Activity

    Patient Rated Tennis Elbow Evaluation It consists of pain subscale and functional subscale, total score is calculated by adding Pain Subscale and Function Subscale then calculated as, Best Score= 0 Worst Score = 100 (pain and disability contribute equally to score)

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2023
  2. Study start1 Mar 2022
  3. Primary completion30 Sep 2022
  4. Study completion1 Nov 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Controlled Trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05698108
Sponsor's protocol ID
ULahore Shazal Nazir
Status last verified
Jan 2023
First submitted
26 Nov 2022
Last updated
26 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Instrument Assisted Soft Tissue Mobilization (IASTM) and Conventional Physical Therapy in people with Lateral Epicondylitis and Tennis Elbow, run by University of Lahore at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain (mild to severe) (time frame: 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in